Deutsche Bank Ag\ Coherus Bio Sciences, Inc. Transaction History

Deutsche Bank Ag\

$212 Billion
Q1 2024

A detailed history of Deutsche Bank Ag\ transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 125,513 shares of CHRS stock, worth $217,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,513

Previous 1,132,239 88.91%

Holding current value

$217,137

Previous $3.77 Million 92.07%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $2.03 Million - $3.16 Million	-1,006,726 Reduced 88.91%	125,513 $299,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $1.73 Million - $4.2 Million	1,090,063 Added 2584.56%	1,132,239 $3.77 Million
Q3 2023 Nov 09, 2023	BUY	$3.74 - $5.45 $46,439 - $67,672	12,417 Added 41.73%	42,176 $157,000
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $75,762 - $165,917	-19,990 Reduced 40.18%	29,759 $127,000
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $1.65 Million - $2.95 Million	-280,232 Reduced 84.92%	49,749 $340,000

Q4 2022 Feb 13, 2023	SELL	$5.69 - $10.07 $1.98 Million - $3.51 Million	-348,122 Reduced 51.34%	329,981 $2.61 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $18,140 - $35,091	-2,530 Reduced 0.37%	678,103 $6.52 Million
Q2 2022 Aug 11, 2022	BUY	$5.86 - $13.23 $1.55 Million - $3.5 Million	264,818 Added 63.69%	680,633 $4.93 Million
Q1 2022 May 13, 2022	SELL	$10.92 - $16.41 $49,478 - $74,353	-4,531 Reduced 1.08%	415,815 $5.37 Million
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $4.19 Million - $5.03 Million	-265,132 Reduced 38.68%	420,346 $6.71 Million
Q3 2021 Nov 04, 2021	SELL	$12.68 - $17.79 $1.89 Million - $2.65 Million	-149,111 Reduced 17.87%	685,478 $11 Million
Q2 2021 Aug 11, 2021	BUY	$12.95 - $15.41 $864,231 - $1.03 Million	66,736 Added 8.69%	834,589 $11.5 Million
Q1 2021 May 13, 2021	BUY	$14.42 - $21.39 $2.42 Million - $3.59 Million	168,044 Added 28.02%	767,853 $11.2 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $89,589 - $102,465	-5,410 Reduced 0.89%	599,809 $10.4 Million
Q3 2020 Nov 12, 2020	SELL	$17.41 - $19.89 $2.57 Million - $2.93 Million	-147,463 Reduced 19.59%	605,219 $11.1 Million
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $3.43 Million - $4.55 Million	237,359 Added 46.06%	752,682 $13.4 Million
Q1 2020 May 14, 2020	BUY	$11.67 - $22.53 $119,104 - $229,941	10,206 Added 2.02%	515,323 $8.36 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $5 Million - $6.55 Million	306,291 Added 154.05%	505,117 $9.09 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $60,831 - $87,216	-3,732 Reduced 1.84%	198,826 $4.03 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $10.4 Million - $17.6 Million	-797,414 Reduced 79.74%	202,558 $4.48 Million
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $11.6 Million - $21.4 Million	-1,382,466 Reduced 58.03%	999,972 $13.6 Million
Q4 2018 Feb 14, 2019	BUY	$8.65 - $16.28 $3.96 Million - $7.45 Million	457,326 Added 23.76%	2,382,438 $21.6 Million
Q3 2018 Dec 21, 2021	BUY	$14.45 - $20.25 $1.43 Million - $2 Million	98,646 Added 5.4%	1,925,112 $31.8 Million
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $7.38 Million - $10.3 Million	510,927 Added 38.84%	1,826,466 $30.1 Million
Q2 2018 Apr 21, 2020	BUY	$10.25 - $17.45 $256,034 - $435,883	24,979 Added 1.94%	1,315,539 $18.4 Million
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $6.22 Million - $10.6 Million	606,739 Added 88.73%	1,290,560 $18.1 Million
Q1 2018 Oct 18, 2019	BUY	$9.1 - $13.7 $735,744 - $1.11 Million	80,851 Added 13.41%	683,821 $7.56 Million
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $2.23 Million - $3.36 Million	245,016 Added 68.45%	602,970 $6.66 Million
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $2.32 Million - $4 Million	277,788 Added 346.52%	357,954 $3.15 Million
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $889,842 - $1.16 Million	80,166	80,166 $1.07 Million

Others Institutions Holding CHRS

# of Institutions

148

Shares Held

82.9M

Call Options Held

184K

Put Options Held

255K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $134M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account